Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06314919
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-03-11
Brief Title:
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of PitavastatinEzetimib
Sponsor:
Boryung Pharmaceutical Co Ltd
Organization:
Boryung Pharmaceutical Co Ltd
Study Overview
Official Title:
A Multicenter Prospective Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of PitavastatinEzetimibe Under the Real-World Condition
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of PitavastatinEzetimibe under the real-world condition
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None